Latest / The Pivot Podcast with Fexingo: How Businesses Change Direction and Survive Disruption / How Aetna Pivoted Through Health Insurance Turmoil
Transcript
- Lucas: Let me start with a number that still catches my attention: seven hundred million dollars. That's how much Aetna lost on its Affordable Care Act individual plans in 2016 alone. Luna: That's a staggering loss for a single line of business in one year. And it wasn't like they were alone—UnitedHealth had already pulled out of most ACA markets the year before. Lucas: Exactly. So by early 2017, Aetna's CEO Mark Bertolini had a brutal choice. They had bet big on the exchanges when the ACA launched in 2014. They expanded to 17 states, offered plans to millions. But by 2016, the math just wasn't working. The risk pool was sicker than expected, premiums couldn't keep up, and the cost of covering people was far above what they'd projected. Luna: And the decision wasn't just about one year's loss. It was strategic. If you stay in a market that's structurally unprofitable, you bleed cash and distract from your core business. So Bertolini pulled the trigger. Lucas: He announced Aetna would exit 80 percent of the ACA individual market. That meant cutting plans in 11 of the 15 states where they were offering coverage. They kept a presence in just four states. For the people who lost their plans, it was disruptive. But from a business perspective, it was a decisive pivot. Luna: And it didn't happen in a vacuum. There was also the failed merger with Humana. In early 2017, a federal judge blocked the $37 billion deal on antitrust grounds. So Aetna had to simultaneously unwind that acquisition and refocus on what they could control. Lucas: That's the part I find most interesting about this pivot. It wasn't a single decision—it was a sequence. First, the merger falls through. Then, the ACA losses force a retreat. But Bertolini didn't just retreat. He redirected. He doubled down on employer-based group insurance, where Aetna had been strong for decades, and on Medicare Advantage. Luna: Which is basically the private version of Medicare—insurance companies manage benefits for seniors, and the government pays them a fixed per-member fee. It's been a huge growth area. Lucas: Right. And Aetna already had a solid Medicare Advantage business. So the pivot was about concentration, not reinvention. They shed the unprofitable individual plans and poured resources into what was already working. By 2017, Medicare Advantage membership grew, and the employer group business held steady. Luna: But wasn't there still a reputational cost? Aetna had been a vocal supporter of the ACA early on. Exiting felt like a reversal. Lucas: Absolutely. And Bertolini took criticism for it. But he framed it as a fiduciary responsibility. He said, 'We cannot sustain a business that loses money year after year. Our obligation is to our shareholders and the 23 million members we serve across other lines.' It's a classic tension in business—between mission and margin. Luna: And that tension only intensified when CVS Health acquired Aetna in 2018 for $69 billion. Suddenly Aetna was part of a drugstore chain with a very different strategy. Lucas: Which made the pivot even more consequential. CVS wanted Aetna's Medicare Advantage expertise to transform its retail clinics into primary care hubs. If Aetna had still been bleeding money on ACA plans, the acquisition might have looked very different. So the retreat from individual plans actually positioned them for that deal. Luna: So the pivot wasn't just about cutting losses. It was about creating optionality. By exiting a broken market, they preserved the financial strength to pursue a bigger opportunity. Lucas: Exactly. And I think that's a lesson that applies beyond health insurance. Sometimes the smartest move isn't to fix a failing product line—it's to redirect your capital and talent toward something that actually has a future. The hard part is having the discipline to walk away, especially when there's public commitment and stakeholder expectations. Luna: And it's worth noting that not every health insurer made the same call. Some, like Molina Healthcare, stayed in the ACA market and eventually found profitability by being extremely disciplined about pricing and geography. So there's no single right answer. Lucas: But for Aetna, the data was clear. In 2016, their individual ACA plans had a medical loss ratio of over 100 percent—meaning they paid out more in claims than they collected in premiums. That's unsustainable. And they had the courage to act on it. Luna: I want to ask about the human side. When you cut 80 percent of a market, you're affecting real people who lost coverage. How did Aetna handle that transition? Lucas: They gave members 90 days notice and worked with state regulators to help people find alternative plans. Some were moved to other insurers, some went to Medicaid. It wasn't seamless, but it wasn't abrupt either. Bertolini said they tried to be 'as responsible as possible' in the exit. Luna: And that's a reminder that pivots have consequences. It's not just a balance sheet exercise. Lucas: Right. And I think that's what makes this case so instructive. Aetna's pivot was a financial necessity, but it was also a strategic repositioning that required tough trade-offs. And in the end, it set the stage for the CVS deal, which has reshaped the healthcare landscape. Luna: So looking back from 2026, how does the Aetna story fit into the bigger picture of health insurance evolution? Lucas: I'd say it's a textbook example of how regulatory risk can force a pivot. The ACA exchanges were a government-created market with unpredictable rules. Aetna's experience shows that even well-capitalized companies can't always make that market work. And it's a cautionary tale for any business entering a heavily regulated space—you need a Plan B. Luna: And it also shows that a pivot doesn't have to be a radical transformation. Sometimes it's about doubling down on what you're already good at and cutting what's dragging you down. Lucas: Exactly. Aetna didn't become a different company. It became a more focused version of itself. And that focus made them attractive to CVS. Luna: Before we wrap, I want to say something about these conversations. If you've been following this podcast and you find these case studies valuable in your work or thinking, it would mean a lot if you considered supporting the show. Lucas: Luna's being modest, but we do put a lot of research into each episode. And listener support is what keeps it ad-free and independent. If that matters to you, you can find us at buy me a coffee dot com slash fexingo. Luna: Yeah, no pressure at all. Just a way to help if the show has moved your work forward in some small way. Lucas: And we're grateful for everyone who listens, regardless. Now, back to Aetna—one final thought. The pivot I described happened in 2017. But the seeds of that decision were planted years earlier, when Bertolini started to see the ACA data turn sour. The best pivots are the ones you prepare for long before you announce them. Luna: So the lesson is: watch your leading indicators. If a line of business is trending toward a $700 million loss, don't wait until you're in the red to act. Lucas: Exactly. Aetna's story is a reminder that the most important pivot is often the one you make before you have to.